spondylitis, ankylosing

Response to: ‘Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis’ by Györfi et al
Milena Gianfrancesco, Kimme L Hyrich, Jinoos Yazdany, Pedro M Machado, Philip C Robinson

Annals of the Rheumatic Diseases Jun 2021, 80 (6) e88; DOI: 10.1136/annrheumdis-2020-218328
Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID)
Alessandro Giollo, Giovanni Adami, Davide Gatti, Luca Idolazzi, Maurizio Rossini

Annals of the Rheumatic Diseases Feb 2021, 80 (2) e12; DOI: 10.1136/annrheumdis-2020-217598
Biologics, spondylitis and COVID-19
James Todd Rosenbaum, Hedley Hamilton, Dongseok Choi, Michael H Weisman, John D Reveille, Kevin L Winthrop

Annals of the Rheumatic Diseases Dec 2020, 79 (12) 1663-1665; DOI: 10.1136/annrheumdis-2020-217941
Classification criteria: time for a rethink?
Duncan Porter, Neil Basu, Stefan Siebert

Annals of the Rheumatic Diseases Oct 2020, 79 (10) 1264-1266; DOI: 10.1136/annrheumdis-2020-217769
Paradoxical gastrointestinal effects of interleukin-17 blockers
Marine Fauny, David Moulin, Ferdinando D'Amico, Patrick Netter, Nadine Petitpain, Djesia Arnone, Jean-Yves Jouzeau, Damien Loeuille, Laurent Peyrin-Biroulet

Annals of the Rheumatic Diseases Sep 2020, 79 (9) 1132-1138; DOI: 10.1136/annrheumdis-2020-217927
Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept
Pierre-Marie Duret, Eden Sebbag, Auriane Mallick, Simon Gravier, Lionel Spielmann, Laurent Messer

Annals of the Rheumatic Diseases Sep 2020, 79 (9) 1251-1252; DOI: 10.1136/annrheumdis-2020-217362
Is a human in vitro enthesitis model relevant to SpA-associated enthesitis? Response to: ‘Beware of wolves in sheep's clothing: immune cell plasticity and instability in health and disease’ by Alunno et al
Abdulla Watad, Hannah Rowe, Darren Newton, Charlie Bridgewood, Dennis G McGonagle

Annals of the Rheumatic Diseases Jun 2020, annrheumdis-2020-218151; DOI: 10.1136/annrheumdis-2020-218151
Response to: ‘Comment on: ‘Successful remission with tofacitinib in a patient with refractory Takayasu arteritis complicated by ulcerative colitis’ by Kuwabara et al’ by Rios Rodriguez et al
Shun Tanimura, Hiroyuki Nakamura, Tetsuya Horita

Annals of the Rheumatic Diseases Jun 2020, annrheumdis-2020-218055; DOI: 10.1136/annrheumdis-2020-218055
Comment on: ‘Successful remission with tofacitinib in a patient with refractory Takayasu arteritis complicated by ulcerative colitis’ by Kuwabara et al
Valeria Rios Rodriguez, Judith Rademacher, Mikhail Protopopov, Murat Torgutalp, Hildrun Haibel, Janis Lucas Vahldiek, Ann-Christin von Brünneck, Safwan Omran, Denis Poddubnyy, Fabian Proft

Annals of the Rheumatic Diseases Jun 2020, annrheumdis-2020-217894; DOI: 10.1136/annrheumdis-2020-217894
Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies
Carlos Sanchez-Piedra, Cesar Diaz-Torne, Javier Manero, José M Pego-Reigosa, Íñigo Rúa-Figueroa, Miguel A Gonzalez-Gay, Juan Gomez-Reino, Jose M Alvaro-Gracia

Annals of the Rheumatic Diseases Jul 2020, 79 (7) 988-990; DOI: 10.1136/annrheumdis-2020-217948

Main menu

spondylitis, ankylosing

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

spondylitis, ankylosing

Pages